The registration, importation and distribution of all heartburn medication containing ranitidine has been suspended in the UAE.
According to the Ministry of Health and Prevention (MoHAP), a circular was issued to health facilities and practitioners informing them about the move.
The decision is based on the recommendations of the US Food and Drug Administration (FDA) and other regulatory bodies regarding a possible contamination of the medicine with an impurity which is classified as potentially carcinogenic.
The Ministry says those wishing to stop taking medicine with ranitidine should consult a healthcare professional for a replacement.
Dubai Mallathon passes 100,000 participants in second edition
UAE issues rainfall alert in several areas from Saturday afternoon
Abu Dhabi reopens parks, beaches after weather improvement
UAE, seven nations urge immediate halt to Israel's E1 settlement plan
Abu Dhabi closes parks, beaches due to weather changes
